appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Transgene Biotek Ltd
TRABI
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Transgene Biotek is a biotechnology company which operates transgene medical centers. Its portfolio of products includes oncology, auto-immunity, drug delivery and biogenerics
PeersCompare with peers
Biocon Ltd
Panacea Biotec Ltd
Hester Biosciences Ltd
Zenotech Laboratories Ltd
Vivo Bio Tech Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Hmm, looks like data is unavailable here. Please come back after some timeRecent EventsAll events
Company Update
TRANSGENE BIOTEK LTD. - 526139 - Intimation Of Book Closure And Cut -Off Date For The 34Th Annual General Meeting Of Transgene Biotek Limited. Register Of Members And The Share Transfer Books Of The Company Will Remain Closed From Friday The 29Th November 2024 To Thursday The 05Th December, 2024 (Both Days Inclusive) For The Purpose Of 34Th Annual General Meeting Which Is Scheduled To Be Held On Thursday The 05Th December 2024 At IST Through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') At 10.00 A.M. (IST). | Download
TRANSGENE BIOTEK LTD. - 526139 - Intimation Of Book Closure And Cut -Off Date For The 34Th Annual General Meeting Of Transgene Biotek Limited. Register Of Members And The Share Transfer Books Of The Company Will Remain Closed From Friday The 29Th November 2024 To Thursday The 05Th December, 2024 (Both Days Inclusive) For The Purpose Of 34Th Annual General Meeting Which Is Scheduled To Be Held On Thursday The 05Th December 2024 At IST Through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') At 10.00 A.M. (IST). | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant